Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives
Authors
Keywords
-
Journal
Annals of the New York Academy of Sciences
Volume 1222, Issue 1, Pages 30-39
Publisher
Wiley
Online
2011-03-22
DOI
10.1111/j.1749-6632.2011.05963.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural Basis for the Dual Recognition of IL-12 and IL-23 by Ustekinumab
- (2010) Jinquan Luo et al. JOURNAL OF MOLECULAR BIOLOGY
- Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial
- (2010) Richard G. Langley et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- (2010) Christopher E.M. Griffiths et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial
- (2009) M. Lebwohl et al. BRITISH JOURNAL OF DERMATOLOGY
- Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population
- (2009) G. Rong et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes
- (2009) Lisa C. Zaba et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-23 Drives Pathogenic IL-17-Producing CD8+ T Cells
- (2009) B. Ciric et al. JOURNAL OF IMMUNOLOGY
- Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
- (2009) Alice Gottlieb et al. LANCET
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
- National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening
- (2008) Alexa B. Kimball et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started